Meclizine

DB00737ApprovedInvestigationalSmall moleculeAntiemeticsHistamine Antagonists

Meclizine is a histamine H1 antagonist used to treat nausea, vomiting, and dizziness associated with motion sickness. It is used in the symptomatic treatment of motion sickness and control of vertigo associated with vestibular system diseases.

Chemical structure of Meclizine
Mechanism
Curator reviewed · 3 references
Primary indication
Indicated for the symptomatic treatment of nausea, vomiting, and dizziness associated with motion sickness, and management of vertigo due to various causes, including radiation sickness, Meniere’s syndrome, labyrinthitis and other vestibular disturbances.Curator reviewed · 3 structured indications
Formula / weight
C25H27ClN2 · 390.948 g/mol (avg)
First approval
Canada, 2007 · United States, 1981
Also known as
Meclozine
Code names
UCB 170 · U.C.B. 5062
Brand names
  • Antivert
  • Bonine
  • Diphen
  • Dramamine
  • Travel-ease

Resolves to

Structure
InChIKeyOCJYIGYOJCODJL-UHFFFAOYSA-NSMILESCC1=CC(CN2CCN(CC2)C(C2=CC=CC=C2)C2=CC=C(Cl)C=C2)=CC=C1

What you can answer from here — as of September 26, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1,117Drug interactionsStructured to mechanism, not free text
Sign in
11Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
1ContraindicationEach with its own population and attribute set
Sign in
455Marketed productsAcross 4 countries and 154 labellers
Sign in
2ATC codesIncluding every combination product, plus 22 drug categories
Sign in
13+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Meclizine, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account